期刊文献+

抗甲状腺药物致粒细胞缺乏症临床分析 被引量:2

暂未订购
导出
摘要 目的 :总结抗甲状腺药物 (ATD)引起粒细胞缺乏症 (粒缺 )的临床特点、治疗措施及ATD引起粒缺的危险因子。方法 :对 12例由ATD引起的粒缺的临床资料作一回顾性分析。结果 :11例由服用他巴唑 (MM)引起 ,1例由服用丙基硫氧嘧啶 (PTU)引起 ,多于服药后 3~ 8周发病 ,粒细胞集落刺激因子 (G CSF)能显著缩短体温恢复正常的时间及粒细胞恢复正常的时间。结论 :MM可能比PTU更易引起粒缺。对服用ATD者均应常规监测白细胞 ,G CSF对ATD引起的粒缺治疗有效。
出处 《温州医学院学报》 CAS 2001年第4期255-256,共2页 Journal of Wenzhou Medical College
  • 相关文献

参考文献7

  • 1[1]Bartalena L, Bogazzi F, Martino E. Adverse effects of thyroid hormone preparations and antithyroid drugs[J]. Drug Saf,1996,15(1):53-56.
  • 2[2]Tamai H, Sudo T, Kimura A,et al. Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease[J]. Ann intern Med,1996,124(5):490-494.
  • 3[3]Meyer Gessner M, Benker G, Lederbogen S,et al. Antithy roid drug-induced agranulocytosis[J]. J Endocrinol Invest,1994,17(1):29-36.
  • 4[4]Chien MN, Wan CH, Tsan KW. Methimazole-induced agranulocytosis treated with recombinant human granulocyte[J]. Chung Hua I Hsueh Tsa Chin Taipei,1995,56(5):351-355.
  • 5[5]Andres E, Maloisel F, Kurtz JE,et al. Do hematopoietic growth factors have a role in the treatment of drug-induced agranulocytosis?[J]. Rev Med Interne,2000,21(7):580-585.
  • 6[6]Iitaka J, Noh JY, Kitahama S,et al. Elevated serum granulocyte colony-stimulating factor levels in patients with Graves disease[J]. Clin Endocrinol Oxf,1998,48(3):278-280.
  • 7[7]Hara H, Ban Y, Sato R,et al. Change in serum G-CSF levels in patients with Graves disease by treatment with methimazole[J]. Nippon Naibunpi Gakkai Zasshi,1992,68(10):1121-1129.

同被引文献37

  • 1荆海燕,陶军,杨晓峰.药物所致脱发[J].医药导报,2002,21(S1). 被引量:1
  • 2安子元,徐计秀,徐大毅,任志刚,郭文东.他巴唑引起肝损害的临床流行病学调查[J].临床消化病杂志,1995,7(4):163-165. 被引量:8
  • 3姜青锋.抗甲状腺药物致肝性昏迷2例[J].中国实用内科杂志,1995,15(12):729-729. 被引量:3
  • 4郑德灏,苏平,方景怡,计启凤.他巴唑治疗甲状腺功能亢进症致肾病综合征一例[J].中华内科杂志,1996,35(4):264-264. 被引量:4
  • 5姜涛 修青.他巴唑致剥脱性皮炎1例[J].中国医院药学杂志,1998,18(10):478-478.
  • 6褚平.丙基硫氧嘧啶致脱发1例[J].宁波医学,1997,9(3):115-115.
  • 7尹洁,付国荣.丙基硫氧嘧啶致药物热1例报告[J].首都医科大学学报,1998,(2):175.
  • 8郑德颐.他巴唑治疗甲状腺功能亢进引起肾病综合症一例报告.中华内科杂志,1982,(5):305-305.
  • 9Dolnan KM, Gans RO, Vervaat TJ, et al. Vascutitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy [ J ].Lancet, 1993, 342: 651-652.
  • 10Nob KY, Asari T, Hamada N, et al. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmitic antibody(MPO-ANCA) in Graves, disease patients treated with propylthiouracil and the relationship between MOP-ANCA and clinical mangestations [J ]. Clin Endocrinol,2001, 54: 651-654.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部